Biotech Industry Faces Uncertain Times, But Hope Lies in Upcoming Drug Trials
The biotech world is going through a tough time right now. So far this year, big companies buying smaller ones […]
New Approach to Treating Chronic Pain Shows Promise
A recent study has found that a new type of medication may be effective in managing chronic pain. This new
Pharmaceutical News
New Cholesterol Drug Shows Promise
A recently conducted study revealed that a new medication, known as Inclisiran, has shown promising results in lowering cholesterol levels.
Important Update on a New Cholesterol-Lowering Drug
There’s good news for those managing high cholesterol levels. A new drug has been shown to significantly reduce ‘bad’ cholesterol,
Pharmaceutical News
New Developments in Medicine Production and Quality Control
Several exciting updates are happening in the world of pharmaceuticals! Here’s a simple breakdown: 1. **Improving Drug Absorption**: There’s a
New Study: Antibiotics Often Prescribed Unnecessarily for Common Cold
A recent study published in the journal ‘Family Practice’ reveals that many doctors are still prescribing antibiotics for common colds,
Uncategorized
Lilly plans to invest $50 billion to expand its manufacturing facilities in the United States. This investment will help produce more medications, including well-known pills like Trulicity and Jardiance, to meet growing demand.
The company is planning to double its investment in U.S. factories. This is happening because President Donald Trump is pushing the pharmaceutical industry to bring drug production back to the United States. Some of the medicines that might be affected include common ones like aspirin or ibuprofen.
Uncategorized
In recent job cuts at the FDA, experts are worried about potential widespread effects. They fear that reducing staff could slow down the approval process for new medications, affecting the availability of important drugs like Advil or Lipitor.
The Trump administration’s decision to cut the FDA’s staff might jeopardize crucial work related to medical devices and food safety. It could also hinder the agency’s ability to gain knowledge in new areas. This might affect the FDA’s work on medications like Advil and Tylenol.
Uncategorized
Pharmaceutical companies that produce customized medications are suing the FDA because the agency announced that the shortage of a weight-loss drug called Wegovy is over. These companies often make their own versions of medications when there is a shortage. Some of the drugs involved include Wegovy and possibly others like Ozempic, which is also used for weight management. The lawsuit likely stems from the fact that once a shortage is declared over, these companies may no longer be allowed to compound their versions of the drug.
Telehealth provider Hims & Hers announced that it will advise customers to look for other dosage options for certain medications. Despite this, the company still expects to see increased revenue and profits in 2025. Some of the medications they offer include sildenafil (generic Viagra) and tadalafil (generic Cialis).
Uncategorized
Eikon, a biotech company, recently raised $351 million, making it one of the largest fundraising events in the biotech sector this year. This funding will help Eikon advance its research and development efforts, though specific drug names were not mentioned in the announcement.
This financing deal is the second-biggest of the year for one of the nearly 24 venture capital firms monitored by BioPharma Dive. It involves investments in the pharmaceutical sector, potentially including companies that develop medications such as Lipitor or Zoloft.